Pfizer COVID-19 Vaccine
Pfizer is Testing a Pill That Could Prevent COVID-19
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit “Cookie Settings” to provide a controlled consent. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.
South Africa to Receive 20 Million Doses of the Pfizer COVID-19 Vaccine
Image sourced from TimesLIVE Pfizer is set to distribute 20 million doses of its COVID-19 Vaccine to South Africa – starting mid-April. This comes after the pharmaceutical company managed to resolve contractual conditions that weren’t in line with South Africa’s normal procurement policies, revealed Department of Health deputy director-general, Anban Pillay. According to Bloomberg, the Pfizer-BioNTech version will be “used to kick-start the rollout after a decision not to use AstraZeneca Plc’s shot, which was found to offer little protection against mild forms of COVID-19 in a local trial”. AstraZeneca Vaccine Only ‘Minimally Effective’ Against South African COVID-19 Variant, says Researcher The AstraZeneca COVID-19 vaccine has proven ‘minimally effective’ against the South African variant...
Pfizer COVID-19 Vaccine Proven ‘Less Effective’ Against South African Virus
Image sourced from TimesLIVE A lab study by Pfizer and BioNTech has shown that its COVID-19 vaccine has proven ‘less effective’ against the South African variant by producing “lower levels of neutralizing antibodies”. According to Bloomberg, the results are “part of tests of its vaccine against a lab-created virus that had all the mutations found in the South African variant, which is thought to spread faster than earlier versions”. “The mutant virus has become a stumbling block for vaccine campaigns, with South Africa halting the rollout of AstraZeneca Plc’s shot after a study showed it didn’t work as well in preventing mild illness involving the variant first identified there”. The AstraZeneca COVID-19 vaccine – of which South Africa has received one million doses – has proven ‘minimally...
AstraZeneca Vaccine Only ‘Minimally Effective’ Against South African COVID-19 Variant, says Researchers
Image sourced from TimesLIVE The AstraZeneca COVID-19 vaccine has proven ‘minimally effective’ against the South African variant, according to the Wits Vaccines and Infectious Diseases Analytics (VIDA) research unit. So far, South Africa has received one million doses of the Oxford/AstraZeneca vaccine. In an official report, researchers from South Africa and the UK found that “viral neutralisation by sera induced by the ChAdOx1 nCoV-19 coronavirus vaccine against the B.1.351 coronavirus variant were substantially reduced when compared with the ‘original’ strain of the coronavirus”. /* custom css */ .tdi_3_ec0.td-a-rec-img{ text-align: left; }.tdi_3_ec0.td-a-rec-img img{ margin: 0 auto 0 0; } Professor of Vaccinology at the University of Oxford, Sarah Gilbert revealed that efforts are alrea...
